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Previously, we reported the presence of group II-like phospholipase A2 activity in the soluble fraction of rat gingiva. In the present study, WC found 
that treatment of rat gingival cells with human recombinant interlcukin- I@ resulted in dose-dependent stimulation of intracellular and extracellular 
phospholipase A2 activity. Antisera against group II phospholipase A2 totally blocked the intcrleukin-I&induced phospholipase A2 activity, but 
antisera against group 1 phospholipasc A. did not. Moreover. immunoblot analysis showed that the induced phospholipase A2 was group II 
phospholipasc Al. These findings suggest that the induced enzyme belongs to the group II phospholipase A2 family of proinflammatory cnyn~cs. 
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1. 1NTRODUCTION 
Phospholipase A2 (PLA,; EC 3.1 .I .4) catalyzes the 
hydrolysis of membrane phospholipids at the sr~-2 posi- 
tion to release arachidonic acid, which is a rate-limiting 
step in the production of prostaglandins and leuko- 
trienes [l]. Low-molecular-mass (14 kDa) PLA2 in 
mammalian tissues can be classified into two types on 
the basis of primary structure, group I PLA, (PLA,-I) 
and group II PLA, (PLA?-II). The latter may partici- 
pate in the inflammatory process in various disorders 
such as rheumatoid arthritis [2]. pancreatitis [3], Gram- 
negative septic shock [4], and inflammatory bowel dis- 
ease [S], and it is believed to be a proinflammatory 
enzyme [G]. Recently, it was reported that high amounts 
of PLAJI were produced in response to interleukin-1 
(IL-I) and tumor necrosis factor, which are potent in- 
flammatory mediators, in rat renal mesangial cells [7] 
and human synovial fibroblasts [8]. Moreover, these 
peptidr: growth factors enhanced not only the activity 
ol’ PLA?-II but also the production of mRNA encoding 
PLA2-II in rabbit chondrocytes [9] and rat vascular 
smooth muscle cells [IOj. 
It has been known for many years that periodontitis 
and rheumatoid arthritis share many common features, 
for exam$e, bone resorption, and high levels of prosta- 
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glandin E2 [11,12] and IL-1 [13,14] in the diseased re- 
gions. In a previous study, we demonstrated PLA2 ac- 
tivity in the soluble fraction from rat healthy gin&al 
tissue, and suggested that it could be PLA--II in terms 
of substrate specificity, Ca?’ dependence, optimum pH 
and sensitivity to detergent [IS], but the details re- 
mained unclear. In the present study, we characterized 
PLA2-II activity produced and secreted extracellulnrly 
by rat gingival Iibroblasts in response to human recom- 
binant IL-IS, and furthermore using antisera against 
PLAJ and PLA,-II, we showed that the activity be- 
longs to the PLA,-II family. 
2. MATERIALS AND METHODS 
2.1. Materiuls 
Recombinant IL-l,0 was purchased from Cienzyme Co., Boston, 
MA. I-Acyl-2.[I-“C]arachidonyl phosphatidylethanolaminc(PE) was 
obtained from Amersham International, UK. 
2.2. Cell cirfIurc 
Gingival fibroblasts were obtained from male Wistar rats by the 
method of Wilhelm et al. as described previously [161. Briefly. the cells 
were grown in Dulbecco’s modified Eagle medium containing 10% 
fetal calf serum, ascorbic acid (50ydml) and antibiotics. Subconfluent 
monolayers of cells (4-6 x IO5 cellsJ60-mm dish) at passages 3-6 were 
used. 
2.3. Treaatettt of ceils wi!h it-i/l and assay jar PLA: activity 
To determine the effect of IL-IS on the levels oT PLAz activity in 
both cells and medium, the cells were washed twice with serum-lice 
medium and then cultured in serum-free medium with variousconcen- 
trations of IL-l/J for up to 48 h. At the end of the incubatio& the 
medium was withdrawn and centrifuged at 250 x g for IO min. The 
supematant was removed and stored at -70°C until assay of Pi-A: 
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activity in the medium. On the other hand, for detcrminution of intra- 
cellular PLAz activity, the cells were washed twice with phosphate- 
buffered saline and scrapLti off with a rubber policeman in 50 mM 
Tris-HCl (pH 7.4). The collected cells were then sonicated (15 s x 2) 
in ice-cold water, followed by centril’ugation at 1,500 xg for 30 min 
and thcsupernatant was used as theenzyme source. The assay of PLAI 
activity was carried out by the modified methods of Nishijima et al. 
[I71 and Shaker [IB]. Briefly the assay mixtures contained 50 mM 
Tris-HCI (pH 7.4), 10 mM CaCI:. 5 PM PE and the enzyme. PLA2 
activity was determined by counting the radioactivity of [ I-“‘Clara- 
chidonic acid released. 
Rat antisera against rat pancreatic PL.4, (anti-PLA,-I) and rat 
splenic PL.42 (anti-PLAl-II) and its IgG fractions (anti-PI-AZ-II IgG) 
were prepared, and purified as dcscribcd previously [l9]. Each anti- 
PLA, serum (55 mg protein/ml) and IgG (13.3 mg protein/ml) were 
diluted IO- to I ,000.fold with phosphate-buffered saline. In the PLA, 
inhibition experiments, 40.~1 ofmedium containing PLAz activity was 
incubated with lO,~l ofthe diluted anti-PLAl antiserum or anti-PLAs- 
II IgG for I h at room temperature. After the incubation, an aliquot 
was taken to deitrmine :bc activity of PLA2, Immunoblot unalyses 
wcrc performed with anti-PLAz-II 1gG as described previously [S]. 
3. RESULTS AND DISCUSSION 
To investigate the effect of IL-lp on the levels of 
PLA? activity in either the cell layers or media, cultures 
were exposed to various concentrations of IL-la from 
1 to 500 U/ml for 24 h as described in Materials and 
Methods. Fig. 1 shows the dose-response ffects of IL- 
18 on PLA? activity in both the intracellular (celi layers) 
and extrucellular (media) fractions. IL-lp increased 
PLA:, activity significantly over each of the control lev- 
els in a dose-dependent manner between 5 and 100 U/ 
ml, showing maximal activity at 100 U/ml and over in 
both fractions. Twelve- and 67-fold increases in PLAL, 
activity over the control were observed at 100 U/ml 
IL-l/3 in the cell layers and media, respectively. A half- 
;: 
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Fig. 1. Dose-response affects of IL-la on intracellular and cxtraccllu- 
IXPLA, activity I Rat gin&al fibroblasts wore incubated for ?4 h With 
various concentrations of IL-lp as indicated in the figure. PLAz activ- 
ity in the medium (W and in the cell layers (0) was determined as 
described in Materials and Methods. Results are means f 5.E.M. for 
a representative of three independent experiments done in triplicate. 
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Pig, 2, Time-course lfect of IL-I/? on intracellular and extracellular 
PI-A, activity. Rat gingival ibroblasts were incubated with IL-l@ (50 
U/ml) for the indicated time periods. PLAz activity in the medium @) 
and in the cell layers (0) was determined as dersribed in Materials and 
Methods. Results are means + S.E.M. for a representative of 3 inde- 
pendent experiments done in triplicate. 
maximal increase (EC,,) was estimated to require 20 
U/ml IL-l@ (5.71 PM). A similar ECSO value of IL-l,8 
has been reported to induce PLA,-II activity in rabbit 
chondrocytes, with a maximum induction of 13 times 
the control level after 24 h of incubation with IL-lp [9J 
In the time-course xperiments shown in Fig. 2, there 
was a lag period of 6 h after the addition of IL-la (50 
U/ml), and thereafter the PLA, activity increased with 
time between 6 and 24 h. About S-fold higher activity 
in the medium than that in the cell layers was observed 
at any of the times examined during the experimental 
period for up to 48 h. Either actinomycin D or cyclo- 
heximide inhibited dose-dependently the PLA, activity 
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Fig. 3. Effects of the antisera on exrracellular PLAz activity. Rat 
gingival fibroblasts were incubated with IL-I/? (50 U/ml) for 24 h. 
Then the medium was incubated with diluted antisc:um against PM,- 
I (0) or PLA,-II (II), or IgG agalhst PLA.-II (0) for I h. After the 
incubation, the residual PLAI activity was assayed as described in 
?-%terials and Methods, Results arc means & S,E,M, for a reprcsenta- 
tive of 3 independent experiments done in triplicate. 
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Fig. 4. Immunoblot analysis of PLA: secreted from rat Bingival Rbro- 
blasts after IL-IS treatment. Lane: (1) PLAYII purified from rat 
spleen; (2 and 3) PLAz partially purified and enriched from culture 
media with an S-Sepharosc colcmn (5 and 10 pg. respectively). Lanes 
2 and 3 were stained for a longer time than lnne I because of their low 
content of libroblast PLAz. 
in the presence of IL-1p (50 U/ml) in the media and the 
cells (data not shown). Total suppression of IL-lgstim- 
ulated PLA,! activity to the basal level occurred at LOT) 
r&ml actinomycin D or 10 ,ug/ml cycoheximide. The 
viability of the cells treated with IL-l/3 was tested by 
Trypan blue dye exciusion and was found to be more 
than 9G% (data not shown). These findings suggest hat 
the intracellular PL& produced through de novo pro- 
tein synthesis is rapidly secreted from the cell into the 
medium after its induction. 
The characteristics of rat pingival PLA2 induced by 
IL-l/3 with regard to substrate specificity, optimum pM 
(pH 8-9) and strict Ca’)+ requirement (I mM) are well 
consistent with those of PLA?-II in human synovial 
fluid [20] and pleural effusion [21] as well as those of 
PLA&I in rat spleen [22] and platelet [23] (data not 
shown). This strongly suggests that the IL-lfi-induced 
PLA, in cultured gingival cells could belong to the 
PLAI-II family. 
To confirm this, we used antisera against rat pancre- 
atic PLA?-I and rat splenic PLA,-II. Fig. 3 shows the 
effects of antisera against PL&-I and PLA,-II on the 
extracellular PLA? activity. The anti-PLAJI antiserum 
inhibited the enzyme activity dose-dependently over a 
serum dilution range of lOOO- to 100-fold, whereas the 
anti-?LA,-I antiserum did not. Moreover. the anti- 
PLAJI IgG abolished Lhe enzyme activity induced by 
IL-18 almost complete!y (96%). Fig. 4 shows the results 
of immunoblot analysis using anti-PLA+ IgG. PLA?- 
II in culture media of gingival cells stimulated by IL-l/3 
was partially purified and enriched with an S-Sepharose 
column as reported previously [22], The antibody re- 
acted well with the fibroblast PLA2, which gave a band 
showing the same mobility as the PLA$I purified from 
rat spleen. All of these data indicate that the extracellu- 
lar and intracellular forms of the IL-IS-induced PLA2 
are indistinguishable from each other. 
It has been reported that IL-1s also increases PLA, 
activity in other fibroblastic cells, i.e. human foreskin 
fibroblasts [24], BALEVc3T3 cells [25] and human syno- 
vial fibrobtasts [26]. However, the magnitude of the 
increases produced by treatment of these cells with IL- 
11 was at most 2-fold, far less than that observed in 
gingival cells (12-fold). It should be noted that no PLA2 
was released into media from human foreskin tibro- 
blasts upon stimulation by IL-l/?, but addition of IL-IS 
to culture medium of human synovial cells resulted in 
marked stimulation of extracellular PEA? activity by 
5.8-370.fold [27]. These findings suggest hat IL-l/5 
elicited synthesis and secretion of PLAz-11 from cul, 
tured fibroblasts may not be a common feature among 
fibroblasts, and that the extents of stimulation vavy ac- 
cording to the origins of the fibroblasts. Interestingly, 
evidence for tissue-specific induction of PLA2-II by 
lipopolysaccharide in the liver has been reported [2S]. 
In conclusion, the results of this study scggest hat 
IL-I/? takes part in eliciting PLA,-II synthesis possibly 
through increased protein and mRNA synthesis, and 
that subsequently the enzyme secreted extracellularly in 
inflamed sites plays a role in the process of periodontal 
inflammation. 
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